Boothbay Fund Management’s Theriva Biologics TOVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.4K | Hold |
35,601
| – | – | ﹤0.01% | 1197 |
|
|
2025
Q1 | $39.2K | Buy |
+35,601
| New | +$39.2K | ﹤0.01% | 1131 |
|
|
2020
Q3 | – | Sell |
-225
| Closed | -$29K | – | 1108 |
|
|
2020
Q2 | $29K | Hold |
225
| – | – | ﹤0.01% | 807 |
|
|
2020
Q1 | $18K | Sell |
225
-15
| -6% | -$1.2K | ﹤0.01% | 715 |
|
|
2019
Q4 | $30K | Hold |
240
| – | – | ﹤0.01% | 711 |
|
|
2019
Q3 | $27K | Hold |
240
| – | – | ﹤0.01% | 641 |
|
|
2019
Q2 | $33K | Hold |
240
| – | – | ﹤0.01% | 595 |
|
|
2019
Q1 | $41K | Hold |
240
| – | – | ﹤0.01% | 610 |
|
|
2018
Q4 | $34K | Buy |
+240
| New | +$34K | 0.01% | 525 |
|